Driven by its war cry to futureproof healthcare systems globally by creating healthy people not patients, Galway-based Cellnutrition Health is in the process of testing and producing a new vaccine for viruses including the ever-mutating COVID-19 as well as bacteria, fungi and parasitic infections.
It will simultaneously be creating a treatment for patients suffering from diseases induced by these pathogens. Cellnutrition Health is currently finalizing agreements with high-profile university laboratories in readiness to enter mainstream human testing to reinforce claims, and to produce a viable all-natural vaccine and therapy for the current COVID-19 Pandemic. Human trials are said to begin by March 2021.
This is after a triumphant clinical treatment and trial conducted over a four-year period in the Middle East between 2016 and 2020 using its breakthrough formula. The trial successfully treated and saved a poultry farm owned by the Evolution Group from Infectious Bronchitis Virus, a member of the Coronavirus family, during a widespread outbreak in the region during the time. Also noteworthy is the victorious outcome of a more recent, smaller mediated human trial conducted to prove the efficacy of its oral dose in humans and to prevent the subjects from contracting SARS-CoV-2.
Aptly named BEEMAR Formula, Vaccine and Immunotherapy, the patent scientifically combines Marine Plasma with non-allergenic, specifically inoculated Lysozymes and derivatives, ethically extracted from parts of Honeybee combs, making it totally natural and safe to use by everyone without side effects.
The first test batches of both the Vaccine and Immunotherapy will be used specifically to prevent and treat COVID-19. It has many other applications and will be made available as oral dose, nasal spray, eye drops, skin patch and injectable.
Backed by robust science, chemistry and biochemistry, the elegance of the successful BEEMAR Formula lies in its all-natural simplicity and proprietary production protocols. It only uses two active ingredients: Marine Plasma and Non-Allergenic Bee products and derivatives, predominantly Lysozymes.
Lysozymes are already well validated, used and highly praised by the healthcare and pharmaceutical industries. These protein-based enzymes are catalysts that speed up chemical reactions in living cells to support life and have predominantly extracted up to now, from Chicken Egg Albumen.
The Lysozymes and Bee derivatives present in BEEMAR are unlike the other Lysozymes and are clinically proven to be effective against pathogens such as COVID-19. This is because Bees are exposed to many more pathogens including those present in Avian and Bat reservoirs. Bees present immunity ahead of time by being constantly exposed to many more pathogens. Their immunity is created by their Lysozymes and certain derivatives present in Hives.
John Kelleher, CEO of Cellnutrition Health says BEEMAR is a 100% effective, scientific, natural, pure, safe, and stable formula to vaccinate and treat a
plethora of viruses, bacteria, and fungi. This includes the Coronavirus. Cellnutrition Health and our first product to market, is not only for the health threat of the moment. We aim to create is a formulaic approach to health and healing the natural way that induces cellular immunity now and looking forward. Our approach stops deaths, infections, lockdowns, and health-led economic downturns. Our licensing model is collaborative and based on partnerships; designed to assist countries, communities and governments produce healthcare solutions such as BEEMAR with our assistance. Just imagine removing the mask without fear. I am personally thrilled with the opportunity to have our Formula further validated by Human Trials.”
